News

Viewing Page 1 of 1 | Showing Results 1 - 4 of 4

One study, multiple immunotherapy combinations for hormone-receptor-positive, HER2-negative breast cancer

April 23, 2018

Women with metastatic hormone-receptor-positive, HER2-negative breast cancer who have progressed after treatment with a CDK4/6 inhibitor may qualify for a newly opened immunotherapy study at Providence Cancer Institute.

Providence Wellness Watch: Breast Cancer Screening

September 01, 2017

Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.

PATINA trial studies targeted therapy for breast cancer

August 28, 2017

Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...

Study examines diagnostic accuracy of breast biopsies

March 18, 2015
A breast biopsy study that included Oregon pathologists found many get it wrong on trickier cancer risk results.
Viewing Page 1 of 1 | Showing Results 1 - 4 of 4